Corvus Pharmaceuticals (CRVS) Net Equity Issued and Repurchased (2015 - 2026)
Corvus Pharmaceuticals (CRVS) reported Net Equity Issued and Repurchased of $189.41 million for Q1 2026, compared with $279,000 a year earlier.
Powered by 
Analysis
Corvus Pharmaceuticals (CRVS) Net Equity Issued and Repurchased (2015 - 2026) Analysis & Trends
For FY2025, Corvus Pharmaceuticals posted Net Equity Issued and Repurchased of $35.75 million, up 92.3% from FY2024.
- Net Equity Issued and Repurchased has a five-year compound annual growth rate of 232.5% (FY2020 to FY2025).
- By year, Net Equity Issued and Repurchased came in at $18.59 million in FY2024, $12,000 in FY2023 and $31.99 million in FY2021.
- The Q1 2026 figure ranks as the highest quarterly Net Equity Issued and Repurchased in data going back to Q1 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Corvus Pharmaceuticals | 969.07 Mn | 457.51 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 189.41 Mn |
| Jun 30, 2025 | 35.47 Mn |
| Mar 31, 2025 | 279,000.00 |
| Dec 31, 2024 | 2.19 Mn |
| Sep 30, 2023 | 8,000.00 |
| Mar 31, 2023 | 4,000.00 |
| Mar 31, 2021 | 31.99 Mn |
| Dec 31, 2020 | 1,000.00 |
| Sep 30, 2020 | 64,000.00 |
| Jun 30, 2020 | 23,000.00 |
| Dec 31, 2019 | 2,000.00 |
| Sep 30, 2019 | 16,000.00 |
| Jun 30, 2019 | 5,000.00 |
| Mar 31, 2019 | 1,000.00 |
| Dec 31, 2018 | -64.48 Mn |
| Mar 31, 2018 | 64.88 Mn |
| Dec 31, 2017 | 597,000.00 |
| Sep 30, 2017 | 126,000.00 |
| Mar 31, 2017 | 8,000.00 |
| Dec 31, 2016 | -1,000.00 |
API Access
Corvus Pharmaceuticals Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=CRVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "CRVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=CRVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();